The zebrafish (Danio rerio) is rapidly becoming a popular model organism in pharmacogenetics and neuropharmacology. Both larval and adult zebrafish are currently used to increase our understanding of brain function, dysfunction, and their genetic and pharmacological modulation. Here we review the developing utility of zebrafish in the analysis of complex brain disorders (including, for example, depression, autism, psychoses, drug abuse and cognitive disorders), also covering zebrafish applications towards the goal of modeling major human neuropsychiatric and drug-induced syndromes. We argue that zebrafish models of complex brain disorders and druginduced conditions have become a rapidly emerging critical field in translational neuropharmacology research.
Endocrine responses
Zebrafish display well-developed functional neuroendocrine systems, generally homologous to those established in mammals. Similar to humans, stress responses in zebrafish are mediated by cortisol activated by the cascade of hypothalamo-putuitary hormones and acting via glucocorticoid receptors 12, 13, 15, 147 . For example, zebrafish cortisol responses strongly parallel behavioral indices of stress, and may be modulated genetically and pharmacologically 12, 13, 42, 121 .
Genetics
Zebrafish have 25 pairs of chromosomes containing >26,000 protein-coding genes 6 . The genetic homology of zebrafish (to mammals and humans) is relatively high, supporting the translational value of zebrafish models. For example, the nucleotide sequence of zebrafish genes shows approximately 70% homology with that of human genes, and 84% of genes known to be associated with human disease have zebrafish counterparts 6 . It is also important to consider the role of genome duplication in zebrafish, which occurred during teleost evolution, resulting in the presence of several copies of multiple genes. Despite this duplication, zebrafish have a very similar number of chromosomes as humans, rats and mice (23, 21 and 20 pairs, respectively), and mounting evidence supports generally conserved genetics and physiology of major brain processes and behavioral traits in rodents and zebrafish, and the duplicated CNS genes seem to mostly encode for proteins with similar (or substantially overlapping) functions and properties.
High-throughput screens (HTS)
Models used in biomedical discovery, testing live organisms and analyzing their responses in a very time-efficient data-dense objective manner, using powerful computeraided methodologies, such as video-tracking tools. HTS, typically analyzing hundreds of compounds per day, are becoming critical for bioinnovation and biotechnology, as they enable quick inexpensive analyses of large libraries of genetic or pharmacological modifiers, rapidly identifying active compounds (hits) or candidate genes. Zebrafish are an excellent organism for HTP (Figure 3d ) [8] [9] [10] 148 , and costs of in-vivo screening of one drug in zebrafish are estimated to be ~$300, which is 500 times cheaper than a similar rat assay 143 . Comparative analysis of cost-efficiency of mouse and zebrafish studies, using an example of a 2-week chronic fluoxetine treatment (n = 15/group, based on 2012-2013 estimates from the Kalueff Laboratory), reveals a 5-fold saving in zebrafish (total $ 562) vs. mouse ($ 2790) experiments of similar design.
Zebrafish strains
See Table 2 for details.
Sensitivity to pharmacological manipulations
Zebrafish are sensitive to all major classes of neurotropic drugs, including antipsychotics, mood stabilizers, anxiolytics, antidepressants, ethanol, sedatives/hypnotics, stimulants, hallucinogens, antiepileptics, anesthetic/analgesics and cognitive enhancers (see Table 3 for details).
Box 2 Molecular genetic tools for zebrafish research
Various 'forward genetic' tools exist to generate random mutations and discover novel genes involved in particular brain functions and behavior in zebrafish. For example, Ethyl-Nitroso Urea (ENU) chemical mutagenesis has been successfully utilized in large-scale mutation screens in zebrafish 149 , whereas viral vector-mediated insertional mutagenesis has also been developed to expedite the identification of the mutated genes 150 . The development of increasingly powerful forward genetic methods continues, including recent conditional gene-trapping and gene-breaking transposon-based approaches 151 and novel high-throughput large-scale loss-of-function screens using the 'Clustered regularly interspaced short palindromic repeats' (CRISPR) system 152, 153 . Numerous 'reverse genetic' methods are also available to functionally characterize a target zebrafish gene of interest by overexpressing or selectively targeting/knocking it out. Analogous to the classical antisense oligonucleotide-based gene knock-down in rodents, the morpholino is currently the most frequently used reverse genetic tool in zebrafish 154 . In addition, the classical 'Targeting Induced Local Lesions in Genomes' (TILLING) method, developed for Arabidopsis, has also been successfully adapted to zebrafish 155 . Most recently, an elegant, efficient and less labor-intensive gene targeting method has been designed using the 'Transcription activator-like effector nucleases' (TALEN) system 156, 157 , likely to revolutionize targeting genes in zebrafish and other model organisms. Also importantly, a large number of genetic markers are available for laboratories still using classical linkage analysis-based mapping with zebrafish (e.g., 158, 159 ). Collectively, this wide range of available molecular genetic tools contributed to the fact that zebrafish has become one of the favorite model organisms in genetics and neurogenetics 5, 160 .
The close parallels between mammalian and zebrafish behavioral paradigms ( Figure 3 , Table 1 ) suggest the evolutionarily conserved nature of many behaviors (and deficits of their control) across species, implying face and construct validity of zebrafish models. Zebrafish are also very cost-efficient, easy to breed, and can be housed in large numbers in relatively small space ( Figure 1a , Box 1). Therefore, they may represent an ideal species for mediumand high-throughput screens (HTS, Figure 2d ) for genetic mutations and small molecules [7] [8] [9] [10] . Here, we review recent successes and existing challenges in this field, and emphasize the developing utility of zebrafish for translational neuroscience, drug discovery and the search for novel candidate genes.
Zebrafish models of brain disorders
Numerous behavioral tests ( Figure 3 and Table 1 ) illustrate how various common neurobehavioral disorders can be modeled or studied in zebrafish. Consider depression, one of the most widespread and severely debilitating brain disorders that affects ~20% of global population at some point during life 11 . Strongly implicated in clinical depression, various genetic factors, environmental stress and neurochemical disturbances seem to play a similar role in zebrafish phenotypes. For example, gr-s357 zebrafish with a mutated glucocorticoid receptor gene display aberrant corticoid biofeedback, increased levels of glucocorticoids, and aberrant behaviors (reduced locomotion, impaired habituation, potentiated startle) that resemble phenotypes seen in clinical depression 12 . Interestingly, antidepressants (such as selective serotonin reuptake inhibitors, SSRIs) normalize some of the mutant phenotypes, paralleling known effects of these drugs in modifying glucocorticoid signaling and alleviating stress disorders in human patients, which also confirms the translational relevance of serotonergic modulation of zebrafish stress responses 12, 13 .
In addition to genetic models, other factors, such as chronic stressors, commonly trigger affective pathogenesis in both clinical and animal studies 14 . For example, the chronic unpredictable stress (CUS) paradigm is a widely used model of experimental stress, in which rodents are subjected to a battery of chronic stressors, such as restraint, crowding, isolation, novelty, temperature change, light, noise and/or predator exposure 14 . Recent studies have successfully applied CUS in zebrafish, which affects shoaling, exploration and anxiety behaviors, as well as alters brain proteome profiles and neurogenesis (the hallmark of affective disorders in rodent models) 15, 16 ; they also show chronic stress-induced memory deficits and elevated cortisol levels 15, 16 , paralleling depression-like states in humans and rodents.
Complementing genetic and experimental manipulations, pharmacological models are also widely used in brain research. For example, depression-like behaviors in humans and rodents can be evoked by reserpine, which depletes brain monoamines by irreversibly blocking vesicular monoamine transporter. The drug induces strong pro-depressant effects in humans, also causing hypoactivity, motor stereotypies, lethargy and anhedonia in rodents 17 . Reserpine treatment and related neurochemical and behavioral deficits are commonly used as a model of depression in rodents, but can also evoke depression-like behavior in zebrafish (including hypolocomotion and disrupted shoaling, resembling motor retardation and social withdrawal symptoms observed in clinical depression) 17 . Emphasizing the role of monoamine dysregulation in depression, these results also support the developing utility of zebrafish to model complex affective brain disorders. Autism spectrum disorder (ASD) represents another cluster of serious behavioral deficits, affecting ~1-2% of the general population. Although the prevalence of ASD is lower than depression or anxiety (which affect >10-15% of the adult population worldwide), autism causes an enormous amount of human suffering, which (if expressed in patient-years; i.e., the number of patients multiplied by the length of time for which the patient suffers from the disease) represents an urgent unmet medical need 18 . In addition to severe behavioral and cognitive impairments, ASD is characterized by high (~90%) heritability, representing one of the most heritable brain disorders in humans 19 . The use of zebrafish to model ASD is supported by several lines of evidence 20 . First, various models relevant to ASD-related social deficits (e.g., social interaction, social preference) have been adapted from rodent studies, and successfully applied to zebrafish paradigms (see examples in Figure 3e , f) 20 . Second, because of the excellent genetic tools developed for the zebrafish, this species is expected to be a useful model organism for human disorders with high heritability, which includes ASD 21 . For instance, the human 16p11.2 locus is tightly linked to ASD, and the homologous region in zebrafish spans genes important for brain development 21 . Likewise, the variants of the MET gene, which encodes a transmembrane receptor tyrosine kinase of the hepatocyte growth factor/scatter factor (HGF/SF), have been linked to greater autism risk in humans 22, 23 . Notably, in zebrafish, met genetic knock-down impairs cerebellar development and facial motor neuron migration 24 . As these genes are important for zebrafish brain development, and ASD is believed to be a disorder of neural development, these findings are likely relevant to ASD pathogenesis, and suggest strong translational relevance of zebrafish models (also see 25, 26 ). Notably, zebrafish embryonic development has been thoroughly characterized because these fish remain practically transparent for the first 2 weeks of life, during which most developmental changes occur (Box 1). Thus, as a result of over four decades of developmental biology research with zebrafish, this species has become one of the most powerful vertebrate tools for embryologists, and may therefore offer uniquely efficient answers to the conundrum of the developmental abnormalities associated with ASD 20 .
A robust and often observed behavioral feature of zebrafish is their propensity to form tight groups, a behavior called shoaling [27] [28] [29] . Shoaling may be induced and quantified in a variety of ways in the laboratory 27, [29] [30] [31] [32] . The developmental trajectory and neurobiological correlates of this social behavior have also started to be investigated 31, [33] [34] [35] [36] . Such studies are noteworthy because they will offer potential tools with which human brain disorders associated with abnormal social behavior may be examined. In addition to ASD, for example, schizophrenia is also characterized by significantly impaired social behavior 37 .
Similarly, several neuropsychiatric conditions, such as depression and anxiety disorders, also include impaired or abnormal social behaviors 38, 39 . Thus, a laboratory species which offers vertebrate system biology with easy to induce and measure social behavior may have important translational relevance 3, 40 .
The latter disorders are only some of many examples (see Table 1 for more details) showing how complex brain disorders may be successfully analyzed in zebrafish. In fact, mounting evidence suggests that various aspects of almost every brain disorder that can be modeled in rodents could also be modeled in zebrafish-perhaps, in a cheaper and more powerful manner.
Zebrafish models of drug-related disorders
Drug-induced disorders are an important area of biomedical research. One of the key examples is addiction, a widespread disorder commonly associated with drug abuse. Complementing traditional (rodent) models, zebrafish are valid translational models to study reward and drug abuse. Both larval and adult zebrafish show high sensitivity to various drugs of abuse ( Figure 4 , Table 3 ), as well as tolerance, clear preference (reward stimuli) for these agents, and withdrawal symptoms 41, 42 . For instance, the effects of alcohol in zebrafish have been studied for more than a dozen years, revealing numerous behavioral changes in fish that resemble those seen in rodents and humans [43] [44] [45] [46] . Acute alcohol reduces zebrafish fear/anxiety at lower doses (increasing 'top' dwelling or reducing erratic movements, also showing stimulant effects, increasing zebrafish speed and aggression), while higher doses induce lethargy and sedation 43, 45 . These changes show a biphasic trajectory in zebrafish that is highly similar to that in rodents and humans 43 . Chronic alcohol exposure also demonstrates parallels between zebrafish and mammals 44, 47 . For example, after continuous alcohol exposure, when briefly challenged by a high acute dose, zebrafish show markedly diminished (or absent) behavioral responses to this challenge. Similarly, withdrawal from chronic alcohol exposure leads to several behavioral and physiological abnormalities that resemble anxiogenic withdrawal symptoms in humans or rodents 42, 43 . Notably, a variety of alcohol effects in humans extends to the social domain, where (in contrast to the common "knowledge" that alcohol facilitates social interaction) it impairs empathy, social problemsolving and the ability to interpret and respond to social signals 48 . Interestingly, a significant impairment in social behavior induced by acute alcohol exposure has also been reported in zebrafish, including reduced responding to conspecifics, as assessed by the increased distance between the focal and the stimulus fish 49 . These changes can be elicited and quantified in a single fish (viewing animated conspecific images moving on a computer screen) or in live freely-moving shoals [27] [28] [29] 49 .
The effects of alcohol have also been investigated in the context of fetal alcohol syndrome 50, 51 . Its milder, but more prevalent form, fetal alcohol spectrum disorders (FASD) represents the largest preventable cause of mental retardation in children, with a huge societal cost and suffering. Modeling FASD in laboratory animals may lead to the discovery of more efficient diagnostic tools (biomarkers) and treatment options. FASD has been modeled in zebrafish by exposing them to low doses of alcohol for short periods of time during early embryonic development 52 . This exposure led to a striking lack of gross anatomical deformities, but caused significant behavioral anomalies in the adult fish, including reduced social cohesion in shoals 31 and increased distance to conspecific stimuli when the individual fish were tested alone 52 , a behavioral impairment that parallels the social deficits seen in FASD children.
Although these examples suggest good face validity (similar appearance of alcohol effects on behavior in zebrafish and humans), the question of construct validity (similar underlying biological mechanisms) is only starting to be addressed in zebrafish models. Nevertheless, the first studies already showed neurochemical changes that resemble those in humans, and also changes in the expression of genes whose sequences are homologous in zebrafish and humans 44, 53 . Here we use only one example to illustrate common underlying mechanisms, the dopaminergic system, in alcohol-induced behavioral changes. Alcohol modulates the dopaminergic system in various species [54] [55] [56] , and, when administered acutely, dosedependently elevates levels of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in zebrafish brain 57 . Chronic alcohol pre-treatment attenuates these acute alcoholinduced changes, demonstrating neuroadaptation in zebrafish dopaminergic system, similar to that found in mammals 44 . Recently, we have also shown that this alcohol-induced increase in dopamine and DOPAC levels correlates with the activity of brain tyrosine hydroxylase, but not monoamine oxidase (A Kalueff, unpublished observations, also see 53 ). Tyrosine hydroxylase is the rate-limiting enzyme in the biosynthesis of dopamine, and zebrafish have two copies of the tyrosine hydroxylase gene (th1 and th2, differentially expressed in the brain and the periphery, respectively 58 ). Despite the differential expression of tyrosine hydroxylase, the levels of both th1 and th2 mRNA increased dose-dependently in response to alcohol in zebrafish larvae 53 . Monoamine oxidase (MAO) is the enzyme responsible for the breakdown of catecholamines, such as dopamine, into DOPAC. Unlike mammals, which have two forms of the MAO gene (MAO-A, MAO-B), only a single MAO gene has been identified in zebrafish 59 . Although zebrafish MAO (zMAO) resembles both MAO-A and MAO-B in humans, zMAO exhibits a higher amino acid sequence homology to human MAO-A 60 . Despite these differences, the biosynthesis pathway of dopamine and the enzymes involved, as well as the behavioral effects and the mechanisms of alcohol action studied so far, show significant similarities between zebrafish and mammals.
The effects of other drugs of abuse have also been investigated in zebrafish. Albeit considered as 'dangerous' drugs of abuse, hallucinogenic drugs often have low-to-mild addictive properties, and are of interest because of their strong psychotropic effects and potential for treating brain disorders, including depression, anxiety and post-traumatic stress 61, 62 . The growing clinical and preclinical interest in hallucinogenic drugs 63 also impacts zebrafish models. Potently affecting human and animal CNS, various hallucinogenic drugs (such as serotonergic psychedelic, glutamatergic dissociative, and cholinergic deliriant agents) have recently been screened in zebrafish 64 . These studies not only revealed prominent behavioral and physiological responses to these psychoactive drugs (similar to those in humans) 64 , but also established striking parallels between the drugs' pharmacological profiles in zebrafish, humans and rodents (Figure 4) . Importantly, we need to know about both positive and negative effects of hallucinogenic drugs 61, 62 . Thus, we can learn from basic studies of hallucinogenic drug action in such animal models 62 and use zebrafish to identify novel promising drugs 65 . For instance, translational studies of therapeutic effects of ketamine (e.g., its putative fast-acting antidepressant profile) and ibogaine (e.g., its potential anti-addictive action) can be empowered by the fact that zebrafish are highly sensitive to these compounds, and represent an excellent tool for dissecting molecular pathways involved in pharmacological action of these drugs [66] [67] [68] . Likewise, targeting unwanted reward and pro-psychotic effects of hallucinogens, these drugevoked behaviors in zebrafish can be useful to both study the molecular mechanisms of such action and to screen novel anti-addictive or antipsychotic agents (see 67, [69] [70] [71] for examples). Consider, for example, schizophrenic patients which are resistant to dopamine antagonists but may markedly benefit from drugs (e.g., clozapine) which act on other neurotransmitters (e.g., serotonin). With no antipsychotic drug currently free of serious side effects or providing complete resolution, we need to identify the mechanisms of these drugs and understand why certain compounds work on some patients and not others, and how their therapeutic effects can be maximized without combined side-effects. Drug candidates that would resolve the above issues can only be discovered through investigation into hallucinogen-evoked mechanisms in animal models 63 , including zebrafish HTS and biosensors 2, 8, 9, 65, 72 , as well as sensitive behavioral tests such as discussed here ( Figure 3 and Table 3 ).
Closely related to the questions on the actions of hallucinogenic drugs is the utility of animal models for the analysis of psychoses [73] [74] [75] . For instance, hallucinogens in animal models successfully mimic the impaired habituation and disrupted pre-pulse inhibition characteristic of schizophrenic patients-two abnormalities potentially responsible for the thought disorder key to the symptoms of the disease 63 . A thorough understanding of the mediatory effects of these compounds is therefore critical, but will only be possible through further research, especially at the pre-clinical stage. Glutamatergic antagonists have long been known to evoke clinical psychoses. In zebrafish, the dissociative hallucinogens ketamine and dizocilpine (MK-801) produce various aberrant behaviors, which resemble those seen in humans and rodents treated with drugs that evoke psychoses, and include cognitive impairment, reduced social interaction, altered anxiety/activity and stereotypic circling 67, 70, 76 (also see Figure 4a for cross-species comparative analyses of doses). Notably, some of these changes can be reversed by antipsychotic drugs 71 , collectively indicating the utility of larval and adult zebrafish to model psychoses and their mechanisms, also demonstrating the potential use of zebrafish in HTS for novel antipsychotic medication.
In addition to the drug-evoked responses discussed above, zebrafish models are very useful for studying selected neurotoxic conditions. For example, serotonin syndrome (SS) is a serious, potentially lethal disorder associated with elevated brain serotonergic function due to an overdose or combined application of several serotonergic drugs 77 . With the increased use of serotonergic medication, SS affects a large portion of general population and is becoming a major biomedical concern 78 . Thus, there is a widely recognized need for novel experimental models of SS 77, 78 . Characteristic behavioral, neuromuscular and autonomic responses are observed in rodents following administration of serotonergic drugs, representing useful experimental models of SS 77, 79 . Exposed to serotonergic agents and their combinations, zebrafish exhibit a characteristic top dwelling (surfacing behavior) and hypolocomotion, which positively correlate with brain serotonin and may therefore represent potential markers of SS-like states in zebrafish 78 . Thus, the zebrafish seems to offer great promise for HTS of novel serotonergic drugs, probing the SS pathogenetic mechanisms and the analysis of drug × gene interactions 78 .
Critical evaluation and future directions
Although there are many human brain disorders whose modeling have been attempted, with some success, using traditional laboratory species (e.g., rats or mice), the zebrafish appears to have an excellent future in this line of research, and offers several important advantages. For example, genetic factors play a key role in pathogenesis of brain disorders [80] [81] [82] [83] , and the utility of experimental models in clinical neuroscience relies on the model's applicability to genetics research. Box 2 summarizes recent successes in applying molecular genetics to zebrafish neuroscience research.
The relatively sophisticated zebrafish behavioral repertoire 84 , including its highly social nature and the fact that it is a diurnal species that relies heavily on vision (the same modality humans use most), make it an excellent tool for investigators interested in the analysis of brain function and dysfunction. In addition to the genetic tools available for the zebrafish (Box 2) 5 , transgenic zebrafish fluorescence-based screens and optogenetic models enable visualization of biological processes in the body, and an unprecedented dissection of circuitry and cellular mechanisms of brain disorders 85, 86 . Zebrafish behavioral models are also characterized by reliance on vision as an important sensory modality. Because humans are also highly 'visual', computer screens 4, 27, 28 and robotic 'fish' 87, 88 can be costeffectively utilized to deliver environmental stimuli to zebrafish in a precise, consistent and automated manner (a method much less applicable to the classical laboratory species, such as nocturnal rodents; but see [89] [90] [91] ). The fact that zebrafish behavioral stimuli can be applied using computer screens or robots is also important methodologically (e.g., providing standardized experimental stimulation vs. the rodent versions, which use less-controllable 'live' stimuli). Similarly, operant behavior may be studied in zebrafish in a manner it is traditionally assessed in rodents. Although zebrafish are unable to press the lever or use touchscreens (as rodents do 90, 91 ) , it is the matter of time before novel technologies are developed to study zebrafish operant behavior. For example, swimming from one designated area to another, detected by sensitive video-tracking systems, is a form of 'operant behavior', a response that can be paired with software-generated positive reinforcement (e.g., automated food delivery or dimming the lights in the tank).
However, like any model organism, the zebrafish also has its limitations. For example, a recognized limitation in zebrafish genetics is the paucity of well-characterized inbred strains 92 . While a growing number of zebrafish strains is becoming available (Box 1), many of them are outbred, have an unclear breeding history, or show only partial inbreeding with heterozygosity at a substantial percentage of their loci 92 . Because some zebrafish strains are recognized as excellent performers, and enable a good analysis of strain differences (Table  2) , the situation is still not as good as with mouse models, where almost 100 wellcharacterized inbred strains (http://phenome.jax.org/) and hundreds of mutants (http:// www.informatics.jax.org/) are available to researchers. Thus, future efforts may be needed to increase the number of available zebrafish strains and increase our understanding of the strain differences in fish neural phenotypes.
In general, no experimental animal model can target the entirety of any complex brain disorder observed clinically in human patients 93 . Thus, using animal models to target core component behaviors which form a part of the disease spectrum becomes a valid strategy of translational research in this field 94, 95 , if phenotypes we assess are quantifiable, and have construct, predictive and face validity 96 . Many questions remain to be addressed in future zebrafish studies. For example, despite the fact that zebrafish are highly social shoaling animals, it is unclear if deficits in fish shoaling behaviors can be compared to complex human ASD-like phenotypes. Specifically, one of the deficits in ASD is alteration in attention processing which may lead to difficulties in interpreting facial expressions [97] [98] [99] . Whether fish shoaling requires similar attention processing has yet to be established. In addition to ASD, many other psychiatric disorders (including aggression, ADHD and schizophrenia) also involve deficits in attention and impulse control. Although this area is outside of the scope of this review, recent studies suggest the translational importance of attention-and impulse control-related phenotypes in zebrafish [100] [101] [102] [103] . Other studies have shown the importance of social (kin) recognition in zebrafish shoaling 104 , revealing the role of olfactory cues from the major histocompatibility complex (MHC) peptides, similar to the well-established role of MHC in social recognition in mammals [105] [106] [107] .
Several important neuropsychiatric domains were not discussed here in-depth because of their coverage by recent comprehensive literature elsewhere. For example, aggressive behavior is another important area in translational biological psychiatry research. Mounting evidence shows that zebrafish display a rich repertoire of aggressive behavior, the neural mechanisms of which can now be dissected to understand the core pathogenesis of aggression 108, 109 . Likewise, aging-related psychiatric disorders and cognitive decline are receiving growing recognition in clinical psychiatry, and have recently been successfully modeled in zebrafish 110, 111 . Bidirectional sensitivity of cognitive phenotypes to various pharmacological modulators 70, [110] [111] [112] further supports the value of zebrafish in this research. The growing interest in using zebrafish to study pathogenic overlap between behavioral and metabolic disorders 113 is also encouraging, and merits further analyses. The utility of zebrafish for substance abuse research is also receiving wide recognition 41, 114 , revealing overt reward responses to drugs of abuse 69, 102, [114] [115] [116] [117] and conserved gene expression and adaptive (compulsive and relapse) behavior to chronic exposure to these drugs 118, 119 .
Furthermore, there is a growing understanding of zebrafish affective (emotionality-related) phenotypes 84 , which may be directly relevant to modeling anxiety, fear/panic, posttraumatic stress disorder (PTSD) and other stress-related human brain disorders (see Table 1 and 120-127 for details). Anxiety-related disorders are the most widespread psychiatric disorders 11 . Combined with analyses of neuroendocrine biomarkers (Box 1), genomic/ proteomic profiling 128, 129 and dissection of the circuitry underlying fish affective behavior 122, 124, 130 , zebrafish studies continue to provide important insights into core, evolutionarily conserved pathobiology of these stress-related disorders.
Concluding remarks
There is an urgent need for novel biobehavioral assays using alternative model organisms, especially those species with sufficient physiological complexity, similarity to humans, and HTS capacity, such as zebrafish 5, 40, 85, 131 . Although scientists traditionally compare laboratory species in terms of what they are better for, the fact that a novel species is added to the repertoire of biomedical tools is important per se. For example, it allows a comparative approach to brain disorders, that otherwise would not be possible. This is critical because comparative studies can uncover evolutionarily conserved functions, mechanisms and targets, which represent the most important 'core' aspects of the disease or function being studied. This approach markedly increases our ability to translate our findings from laboratory animal model to human disease.
In summary, zebrafish models are becoming an important tool expected to advance neuroscience and neurogenetics. Zebrafish sensitivity to all major neurotropic drugs (Table  3 ) and the ability to respond to them in a similar manner as humans (Figure 4 ) support their utility for pharmacological research. Representing an ideal organism for disease modeling and HTS, as well as possessing high physiological and genetic homology to humans, zebrafish prove increasingly useful in translational biomedical research, and are well suited to meet the rapidly growing challenges of this field.
Highlights
• The zebrafish is a popular novel model in pharmacogenetics and neuropharmacology
• Both larval and adult zebrafish models contribute to studying complex brain disorders
• Zebrafish are highly sensitive to major classes of neurotropic drugs active clinically
• Zebrafish models emerge as a useful tool for genetic screening and drug discovery Table 2 for zebrafish strain information). (d) The growing number of published zebrafish models (assessed in Pubmed in September 2013, using terms "zebrafish" and "behavior"). Tables 1 and 3 for details (note that toxicology studies were not included here). shows zebrafish and human data for selected serotonergic drugs, including lysergic acid diethylamide (LSD), mescaline (Mes), psilocybin (Psi), and 3,4-methylenedioxymethamphetamine (MDMA); 'Normalized' logarithmic dose range is 0.1-120 mg/L for zebrafish and 0.0001-4 mg/kg for humans 140 . Collectively, these data show similar ranking of drugs' activity across various species, illustrating translational value of zebrafish models for screening clinically active neurotropic drugs. Table 1 Selected key neurophenotypic domains and associated disorders modeled in zebrafish (also see timeline in Figure 2 , and zebrafish behavior catalog in 84 ).
Domain/disorder Zebrafish phenotypes References
Anxiety/fear-related behavior Reduction of exploration (especially in the top part of novel tanks), increased avoidance, erratic behavior and freezing, elevated cortisol and brain c-fos; highly sensitive to anxiolytic and anxiogenic agents 4, [123] [124] [125] [161] [162] [163] [164] Mood/depression Reduced activity (motor retardation) accompanied with chronic elevation of cortisol; responses can be reversed by antidepressant treatment 12, 17, 127 Cognitive behavior Excellent short-term and long-term memory tested in various memory and learning tasks; sensitive to amnestic and promnestic agents 111, 112, 165, 166 Social behavior Robust social behavior; sensitive to drugs (e.g., increasing or reducing shoaling responses) [27] [28] [29] 32 Psychoses Hyperactivity, impaired cognitive processes (startle, pre-pulse inhibition) by propsychotic agents; rescued by antipsychotic drugs 8, 9, 167 Attention deficit hyperactivity (ADHD)
Impulsive hyperactive locomotion rescued by anti-ADHD agents 168 Reward-related behavior Robust preference for rewarding stimuli, including food and abused substances 41, 69, [115] [116] [117] 169 Pain Robust pain responses to nociceptive stimuli, and their inhibition with analgesic drugs [170] [171] [172] Epilepsy Hyperactivity and seizure-like behavior, brain spikes (EEG) and c-fos up-regulation; rescued by anti-epileptics 173, 174 Neurodegeneration Decline in locomotion, accompanied by characteristic biomolecular and cellular markers of neurodegeneration 1, 146, 175 Serotonin syndrome (SS) Characteristic surfacing behavior in response to drugs (and their combination) known to evoke clinical SS 78 Eating disorders Increased or reduced eating behavior (similar to anorexia and obesity); highly sensitive to drugs affecting appetite and mediating metabolic phenotypes 113, 176 Sleep disorders Robust circadian rhythms bidirectionally sensitive to sleep-modulating drugs 110, [177] [178] [179] [180] [181] [182] [183] Trends Pharmacol Sci. Author manuscript; available in PMC 2015 February 01. 
